title: Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.
authors.forename: Miriam
authors.initials: M
authors.lastname: Lenhard
authors.forename: Tereza
authors.initials: T
authors.lastname: Lennerová
authors.forename: Nina
authors.initials: N
authors.lastname: Ditsch
authors.forename: Steffen
authors.initials: S
authors.lastname: Kahlert
authors.forename: Klaus
authors.initials: K
authors.lastname: Friese
authors.forename: Doris
authors.initials: D
authors.lastname: Mayr
authors.forename: Udo
authors.initials: U
authors.lastname: Jeschke
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018269:Carcinoma, Endometrioid / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology; D011962:Receptors, FSH / Q000378:metabolism*; D011974:Receptors, LH / Q000378:metabolism*; D015996:Survival Rate; D055815:Young Adult
chemical_list: D011962:Receptors, FSH; D011974:Receptors, LH